This analysis may provide important insight for surgeons, pharmacists and hospital administrators looking for possible ways to help improve patient outcomes and provide savings to the hospital system. The use of opioids alone has been a mainstay for acute pain management. There is an overreliance on opioids as monotherapy to treat acute pain in U.S. hospitals today and 7 out of 10 hospital patients treated with intravenous (IV) analgesia receive IV opioids alone. These results suggest that a multimodal analgesia approach to pain management with OFIRMEV, combined with a reduction in dosing levels of opioids, may contribute to reduced costs and improved outcomes for surgical patients.
To learn more, please click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
